RSE: LJM1R Statistics
Total Valuation
AS Latvijas Juras medicinas centrs has a market cap or net worth of EUR 5.28 million. The enterprise value is 4.45 million.
Market Cap | 5.28M |
Enterprise Value | 4.45M |
Important Dates
The last earnings date was Wednesday, November 27, 2024.
Earnings Date | Nov 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 279,920 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 0.86 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.71, with an EV/FCF ratio of 107.40.
EV / Earnings | -5.86 |
EV / Sales | 0.44 |
EV / EBITDA | 10.71 |
EV / EBIT | n/a |
EV / FCF | 107.40 |
Financial Position
The company has a current ratio of 0.89
Current Ratio | 0.89 |
Quick Ratio | 0.80 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -11.66% and return on invested capital (ROIC) is -1.97%.
Return on Equity (ROE) | -11.66% |
Return on Assets (ROA) | -1.37% |
Return on Capital (ROIC) | -1.97% |
Revenue Per Employee | 27,856 |
Profits Per Employee | -2,078 |
Employee Count | 366 |
Asset Turnover | 1.07 |
Inventory Turnover | 60.81 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.67% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -34.67% |
50-Day Moving Average | 6.88 |
200-Day Moving Average | 8.96 |
Relative Strength Index (RSI) | 44.90 |
Average Volume (20 Days) | 9 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AS Latvijas Juras medicinas centrs had revenue of EUR 10.20 million and -760,420 in losses. Loss per share was -0.95.
Revenue | 10.20M |
Gross Profit | 948,949 |
Operating Income | -208,283 |
Pretax Income | -759,531 |
Net Income | -760,420 |
EBITDA | 415,575 |
EBIT | -208,283 |
Loss Per Share | -0.95 |
Balance Sheet
Cash & Cash Equivalents | 827,126 |
Total Debt | n/a |
Net Cash | 827,126 |
Net Cash Per Share | n/a |
Equity (Book Value) | 6.15M |
Book Value Per Share | 7.69 |
Working Capital | -169,200 |
Cash Flow
In the last 12 months, operating cash flow was 430,754 and capital expenditures -389,295, giving a free cash flow of 41,459.
Operating Cash Flow | 430,754 |
Capital Expenditures | -389,295 |
Free Cash Flow | 41,459 |
FCF Per Share | n/a |
Margins
Gross margin is 9.31%, with operating and profit margins of -2.04% and -7.46%.
Gross Margin | 9.31% |
Operating Margin | -2.04% |
Pretax Margin | -7.45% |
Profit Margin | -7.46% |
EBITDA Margin | 4.08% |
EBIT Margin | -2.04% |
FCF Margin | 0.41% |
Dividends & Yields
AS Latvijas Juras medicinas centrs does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -14.62% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AS Latvijas Juras medicinas centrs has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.99 |
Piotroski F-Score | n/a |